The central insight of the review is that hypoxaemia and impaired carbon dioxide clearance in ARDS are not two versions of the same problem. Low arterial oxygen is driven predominantly by intrapulmonary shunt, meaning blood that perfuses alveoli which are no longer ventilated and therefore returns to the circulation without ever picking up oxygen. Carbon dioxide retention, by contrast, is a consequence of increased dead space ventilation, where air moves in and out of the lungs but never reaches perfused alveoli where gas exchange could occur. Both problems sit on a continuum of disturbed ventilation-perfusion relationships, but they demand different therapeutic logic, and conflating them is one of the most common interpretive errors at the bedside.

The authors begin with the alveolar gas equation, the foundational tool that sets the theoretical ceiling for arterial oxygenation. In a homogeneous lung, the alveolar oxygen pressure is determined by three variables: the composition of inspired gas, alveolar ventilation as reflected by alveolar carbon dioxide tension, and the respiratory exchange ratio, which is the ratio of carbon dioxide production to oxygen consumption. Notably, the equation shows that alveolar oxygen pressure is independent of mixed venous oxygenation, a point with major clinical consequences later in the analysis. Because carbon dioxide diffuses rapidly and almost completely across the alveolar-capillary membrane, and because the carbon dioxide dissociation curve is nearly linear, arterial carbon dioxide closely tracks its ideal alveolar counterpart, making it a reliable surrogate in the equation.

From this foundation flows the alveolar-arterial oxygen difference, normally a modest 10 to 15 millimetres of mercury. This gradient remains normal in isolated hypoventilation or when breathing low-oxygen mixtures, but widens whenever ventilation-perfusion mismatch, shunt, or diffusion limitation is present. The review cautions, however, that the gradient is not a fixed property of the lung: because alveolar oxygen pressure rises more steeply than arterial oxygen pressure as inspired oxygen increases, the difference grows with the fraction of inspired oxygen, limiting its reliability at high inspired oxygen concentrations. A patient’s gradient on 100 percent oxygen cannot be directly compared with the same patient’s gradient on 40 percent oxygen, a subtlety that matters when tracking disease progression.

The conceptual heart of the review is the classical three-compartment model introduced by Riley in 1949, which simplifies the continuous spectrum of ventilation-perfusion ratios into ideal units, shunt units with a ratio of zero, and dead space units with an effectively infinite ratio. ARDS is characterized by a pathological mixture of all three: shunt, regions of very low ventilation-perfusion ratio, and expanded dead space. Diffusion limitation, often invoked intuitively, plays a minimal role in practice, because the high inspired oxygen concentrations used in these patients and the rapid equilibration of carbon dioxide make diffusion barriers almost irrelevant in ventilated units. At a normal ratio of roughly 0.8, alveolar oxygen and carbon dioxide pressures approximate 100 and 40 millimetres of mercury respectively; as the ratio falls, alveolar gas composition drifts toward mixed venous values, and as it rises, it approaches inspired gas.

Quantifying shunt is where physiology meets haemodynamics, and this is the section with perhaps the most surprising bedside implications. The Berggren equation estimates the physiological shunt fraction from the oxygen contents of ideal end-capillary, arterial, and mixed venous blood. But arterial oxygenation depends not only on the shunt fraction; it depends equally on mixed venous oxygenation, which the Fick principle ties directly to cardiac output. For a fixed shunt fraction and metabolic rate, a fall in cardiac output lowers mixed venous oxygen content, and the desaturated venous blood passing through shunted units drags arterial oxygen down with it, even though the lung itself has not changed at all. The authors cite a striking numerical example: on 100 percent oxygen with a fixed 20 percent shunt, arterial oxygen pressure may exceed 400 millimetres of mercury at normal cardiac output but fall below 150 when output is low. PaO2, in other words, is an unreliable index of lung function whenever the circulation is unstable.

The feedback loop runs in both directions. The shunt fraction itself is not fixed, because a rise in cardiac output raises venous oxygen tension, which attenuates hypoxic pulmonary vasoconstriction, the reflex that redirects blood away from poorly ventilated lung regions. Higher cardiac output can therefore simultaneously improve mixed venous oxygenation and worsen venous admixture by redistributing perfusion toward poorly ventilated units. The net effect on arterial oxygen depends on which mechanism dominates in a given patient, which explains why interventions that boost cardiac output sometimes improve oxygenation and sometimes worsen it, and why the review warns against reading oxygen numbers without simultaneously reading the circulation.

These caveats strike directly at the most widely used severity metric in critical care: the PaO2/FiO2 ratio, which underpins the Berlin definition of ARDS. The ratio is intended as a surrogate for shunt fraction, but it is sensitive to inspired oxygen concentration, positive end-expiratory pressure, and cardiac output. Because of the non-linear interaction between inspired oxygen, haemoglobin saturation, and venous admixture, simply changing the FiO2 can alter the ratio without any change in the underlying shunt. The same patient can be classified into different severity categories under different ventilator settings, and the review notes that prognostic accuracy improves when the ratio is measured under standardized PEEP and FiO2 conditions.

On the carbon dioxide side, the review walks through the family of dead space measurements, each capturing a different physiological slice. The Bohr equation, computed with mean alveolar carbon dioxide from volumetric capnography, isolates true dead space, comprising the conducting airways and high ventilation-perfusion units, and is unaffected by shunt. The Enghoff modification, which substitutes arterial carbon dioxide, reflects global gas exchange impairment rather than true dead space alone, and a high shunt fraction can inflate the Enghoff value even in the absence of genuine alveolar dead space. The Fowler method measures anatomical dead space by single-breath washout, and because this volume is relatively constant, tidal volume strongly influences the dead space fraction: the same 150 millilitres of anatomical dead space represents a fraction of 0.25 at a tidal volume of 600 millilitres but 0.50 at 300 millilitres, which is why the authors recommend reporting dead space in absolute millilitres per breath as well as a fraction.

The clinical payoff is prognostic. The Enghoff dead space fraction independently predicts mortality in ARDS, reflecting the degree of functional lung impairment and ventilation-perfusion heterogeneity, and the end-tidal to arterial carbon dioxide ratio offers a bedside surrogate that integrates dead space, shunt, and ventilation-perfusion mismatch, falling progressively as disease severity increases. For units without capnography, the ventilatory ratio, calculated from measured minute ventilation and arterial carbon dioxide against predicted values, requires no expired gas analysis and also independently predicts mortality. The authors close with a message that is both a warning and an invitation: shunt is the principal determinant of hypoxaemia, dead space reflects structural heterogeneity and carries independent prognostic weight, and every bedside index, from PaO2/FiO2 to end-tidal carbon dioxide, must be interpreted through the physiology it actually measures rather than the number it displays.

Subject of Research: Physiological principles of gas exchange and bedside indices in acute respiratory distress syndrome

Article Title: Principles of gas exchange in ARDS: a bedside physiological approach

Article References: Collino, F., Camporota, L., & Pinsky, M. R. (2026). Principles of gas exchange in ARDS: a bedside physiological approach. Intensive Care Medicine. https://doi.org/10.1007/s00134-026-08601-4

Image Credits: AI Generated

DOI: 10.1007/s00134-026-08601-4

Keywords: ARDS, gas exchange, intrapulmonary shunt, dead space, ventilation-perfusion mismatch, alveolar gas equation, PaO2/FiO2 ratio, cardiac output, hypoxic pulmonary vasoconstriction, volumetric capnography, ventilatory ratio, critical care

The research team, led by investigators at Trinity College Dublin and collaborating institutions, focused on two distinct but related markers of exercise tolerance. The first was peak oxygen uptake, or VO2peak, the maximal amount of oxygen the body can consume during incremental exercise to exhaustion. VO2peak is not merely a laboratory curiosity; it is one of the strongest independent predictors of cardiovascular and all-cause mortality, and people with type 2 diabetes consistently show reductions of roughly twelve to twenty-two percent compared with healthy peers. The second marker was the time constant of the primary phase of the oxygen uptake response, abbreviated as tau VO2p, which describes how quickly oxygen consumption rises toward its steady state when a person transitions from rest to moderate exercise. Slower kinetics mean a larger oxygen deficit at the onset of activity, greater reliance on anaerobic metabolism, and earlier fatigue during everyday tasks such as climbing stairs or carrying groceries.

Participants were stratified into two age cohorts: an early middle-aged group aged thirty-seven to fifty-nine years and a late middle-aged group aged sixty to seventy years. All had been diagnosed with type 2 diabetes for fewer than ten years and had glycated hemoglobin values below ten percent, indicating reasonably well-controlled disease. After an initial treadmill electrocardiogram stress assessment, volunteers were assigned to one of four groups: exercising or non-exercising controls in each age band. The allocation was not random, primarily because of differences in participants’ ability to travel to the training facility, a limitation the authors acknowledge. Those in the exercise arms completed a twelve-week supervised program of up to thirty-six sessions, combining continuous cycling at seventy to eighty percent of maximal heart rate, resistance training for major upper and lower body muscle groups at sixty to seventy percent of one-repetition maximum, core strengthening, flexibility work, and brief high-intensity intervals at approximately ninety percent of maximal heart rate. Adherence was exceptional, with participants averaging thirty-five of a possible thirty-six sessions.

The testing protocol was rigorous. Before and after the intervention, participants performed a graded exercise test on a cycle ergometer to determine VO2peak, peak power output, the power output at the gas exchange threshold, and the oxygen pulse, an indirect marker of stroke volume. In a separate session, they completed six constant-load cycling bouts at a workload corresponding to eighty percent of their individually determined gas exchange threshold, with breath-by-breath gas exchange measured continuously. Cardiac output was assessed by an inert gas rebreathing technique at rest and at thirty and two hundred forty seconds of exercise, allowing the researchers to calculate stroke volume, mean arterial pressure, and systemic vascular conductance. The oxygen uptake data were fitted with monoexponential or biexponential mathematical models to extract the time constant of the primary response, the parameter that captures how efficiently the oxidative system adjusts to a sudden metabolic demand.

The results were unambiguous for the exercising groups. Both the early and late middle-aged training cohorts showed statistically significant increases in absolute and relative VO2peak, rising from roughly twenty-five milliliters per kilogram per minute at baseline to about twenty-eight after training, an improvement of approximately twelve percent. Peak power output, the power output at the gas exchange threshold, and oxygen pulse all rose in parallel, while heart rate at exhaustion was unchanged, indicating genuine physiological adaptation rather than simply greater effort or familiarization with the test. Crucially, the magnitude of these gains did not differ between the two age groups. The non-exercising controls, by contrast, showed no meaningful changes in any of these variables over the twelve weeks, and body mass and HbA1c remained stable across all groups, meaning the fitness improvements could not be attributed to weight loss or better glycaemic control.

The oxygen uptake kinetics data told a similarly encouraging story. The time constant of the primary VO2 response fell from approximately forty seconds at baseline to around thirty-four to thirty-five seconds after training in both exercise groups, representing an acceleration of roughly twelve percent in the late middle-aged cohort and twenty-one percent in the early middle-aged cohort. Although the numerical difference between the age groups was noticeable, statistical testing showed it did not reach significance, and the authors concluded that the improvement in submaximal oxygen kinetics was essentially equivalent across ages. This matters because faster kinetics reduce the oxygen deficit at the start of exercise, limit the accumulation of metabolites that contribute to fatigue, and translate directly into better tolerance of the repetitive, moderate-intensity activities that define daily life, an effect that is particularly relevant for adults in their sixties who may be approaching the threshold of functional decline.

Perhaps the most intriguing mechanistic finding was what did not change. The researchers had hypothesized that faster oxygen uptake kinetics might be driven by improved central cardiovascular delivery of oxygen, reflected in more rapid adjustments of cardiac output, stroke volume, or systemic vascular conductance during the first seconds of exercise. Instead, when they quantified the dynamic responses of these variables by comparing the change at thirty seconds with the change at two hundred forty seconds, they found no significant alterations following training in either age group. The improvements in cardiac output and vascular conductance that were observed at fixed time points largely reflected the higher workloads participants could sustain after training rather than a fundamentally altered cardiovascular response profile. This pattern suggests that the acceleration of oxygen uptake kinetics was more likely mediated by peripheral adaptations, such as enhanced matching of oxygen delivery to metabolic demand within the contracting skeletal muscle, improved vasodilatory capacity, or better dynamic microvascular function, although the study did not directly measure muscle oxygenation.

The clinical implications are considerable. Type 2 diabetes prevalence rises sharply with age, and as populations grow older and more sedentary, the burden of the disease is projected to escalate. Previous work by the same group had shown that middle-aged adults with diabetes in their forties and fifties exhibit slowed oxygen uptake kinetics compared with healthy controls, whereas those in their sixties do not, hinting that age might modify the exercise phenotype of the disease. The new data extend that picture by demonstrating that, regardless of these baseline differences, the responsiveness to structured training, in both maximal and submaximal measures of exercise tolerance, is preserved across early and late middle age. In practical terms, clinicians can reasonably expect a sixty-three-year-old with well-controlled type 2 diabetes to gain as much fitness from a twelve-week combined program as a fifty-four-year-old with the same disease duration, which argues strongly against the assumption that older middle-aged patients are somehow less trainable.

The authors are careful to note the boundaries of their conclusions. The participants had relatively mild, uncomplicated diabetes with mean HbA1c values between 6.3 and 7.0 percent, so the findings may not generalize to people with poorer glycaemic control or advanced disease, who typically show greater impairments in fitness. The age gap between the two cohorts was only about ten years, limiting inferences about broader age-related differences in trainability, and the sex distribution differed between groups, although prior evidence indicates that training adaptations in VO2peak and oxygen kinetics are not influenced by sex in type 2 diabetes. The inert gas rebreathing technique also lacked the temporal resolution to detect subtle changes in central hemodynamics. Even so, the study provides a valuable benchmark for expected training responses in adults with type 2 diabetes in their forties through sixties, and it reinforces a message that exercise physiologists have long championed: the aging body, even one carrying a metabolic disease, retains a striking capacity to grow fitter when given the right stimulus. Whether the same plasticity extends to people over seventy or with longer disease duration remains an open and clinically urgent question.

Subject of Research: Effects of structured exercise training on cardiorespiratory fitness and oxygen uptake kinetics in early versus late middle-aged adults with type 2 diabetes

Article Title: Exercise training improves cardiorespiratory fitness and oxygen uptake kinetics to a similar extent in early and late middle‐aged adults with type 2 diabetes

Article References: Exercise training improves cardiorespiratory fitness and oxygen uptake kinetics to a similar extent in early and late middle‐aged adults with type 2 diabetes. (n.d.). https://doi.org/10.14814/phy2.71107

Image Credits: AI Generated

DOI: 10.14814/phy2.71107

Keywords: type 2 diabetes, exercise training, cardiorespiratory fitness, oxygen uptake kinetics, VO2peak, middle age, cardiac output, skeletal muscle, aging, physical activity, Physiological Reports, vascular function

The review organizes the sprawling literature by sensing modality. Seismocardiography, or SCG, records local translational accelerations of the sternum produced by valve motion and myocardial contraction. Ballistocardiography, or BCG, captures the whole-body recoil forces generated when the heart ejects blood into the aorta, and can be measured from a simple weighing scale, a bed frame, or a seat cushion. Gyrocardiography, or GCG, adds the rotational component of chest-wall motion, while kinocardiography, or KCG, fuses sternal and lumbar inertial sensors into a twelve-channel description of cardiogenic body motion. Each modality produces characteristic waveforms with fiducial points tied to specific cardiac events, such as aortic valve opening and closure, and these timing anchors form the raw material for every downstream estimation model.

The authors’ central methodological complaint is that the field has repeatedly confused physiological plausibility with clinical validation. Correlation coefficients, the most commonly reported statistic, are a particular target of their criticism. A device that reads one liter per minute too high in every patient can achieve a correlation of 0.95 with a reference method and still be clinically useless, because correlation measures linear association rather than agreement. The appropriate tool for method comparison is the Bland-Altman analysis, which reports mean bias and the 95 percent limits of agreement between the new method and the reference standard. The review also establishes a hierarchy of reference standards, giving the greatest weight to direct quantitative measurements such as the Direct Fick technique, thermodilution during right heart catheterization, invasive arterial pressure, and cardiac MRI-derived volumes, and treating echocardiographic and cuff-based comparators as weaker evidence.

By these standards, stroke volume and cardiac output estimation emerge as the field’s strongest suit. The most convincing evidence comes from a multi-signal cardiac scale validated against the Direct Fick method in 32 patients with unexplained dyspnea, which reported a stroke volume bias of just 1.58 milliliters with limits of agreement spanning roughly 40 milliliters, a cardiac output bias of 0.31 liters per minute, and a trending concordance of 96.7 percent, all without requiring per-patient invasive calibration. A separate deep learning study estimated cardiac output from 30-second triaxial SCG recordings combined with ECG and body mass index in heart failure patients undergoing right heart catheterization, reporting a bias of 0.35 liters per minute with tight limits of agreement. Both studies, however, were single-center and cross-sectional, and neither establishes that vibration-based monitoring outperforms established non-invasive alternatives in its intended setting.

The technical machinery behind these results is worth appreciating. Scale-based BCG pipelines filter the force channel in a narrow 1 to 15 hertz band for amplitude features, deliberately using linear-phase filters to avoid distorting the timing of fiducial points, and average eight to sixteen consecutive R-wave-triggered beats to suppress respiratory noise. Body weight and basal impedance serve as correction inputs that compensate for inter-individual differences in signal propagation, eliminating the need for a calibration catheterization in every new user. On the SCG side, convolutional neural networks process raw triaxial waveforms directly, learning temporal and cross-axis patterns without explicit annotation of valve events. Yet the review notes that even the best percentage errors hover near or above the 30 percent benchmark historically cited for interchangeability with thermodilution, a figure that itself reflects the uncertainty of the reference method rather than an absolute threshold of clinical meaningfulness.

Ejection fraction tells a very different story. Despite abundant publications, no study has reported Bland-Altman bias and limits of agreement for continuous EF estimation from vibration signals against echocardiographic or MRI-derived values. What does exist is phenotyping: kinocardiographic kinetic energy metrics, computed as time integrals of kinetic energy and maximum instantaneous power across twelve sensor channels, separated heart failure patients with reduced ejection fraction from those with preserved EF in a cohort of 126 patients, achieving an area under the curve above 0.85 and independent prognostic value. That is a clinically meaningful mechanical biomarker, the review argues, but some secondary literature has wrongly conflated it with continuous EF estimation, which it is not. A convincing EF estimator would need to specify target agreement bounds and validate them prospectively in cohorts spanning the clinical EF range, something that has never been done.

Early diastolic SCG features, which researchers hope could one day assess diastolic dysfunction non-invasively, remain even more exploratory. Correlations of roughly 0.71 between diastolic SCG morphology and tissue Doppler e-prime velocity suggest the signal genuinely encodes relaxation mechanics, and preload perturbation experiments show the waveform responds directionally to changes in venous return. But this sensitivity cuts both ways: the same features that track relaxation also respond to loading state independently of intrinsic diastolic function, a confound that any estimation model ignoring volume status would inherit. The review identifies multivariate models with loading-state covariates, tested in heart failure with preserved ejection fraction cohorts, as the obvious next experiment.

Blood pressure estimation earns the most cautious assessment of all. Vibration-based approaches replace the ECG R-wave with a BCG or SCG event as the proximal timing reference for pulse transit time, on the theory that this reduces the electromechanical delay ambiguity that limits conventional ECG-PPG methods. In practice, the vibration landmarks are themselves sensitive to preload and contractility, partially reintroducing the problem they were meant to solve. Worse, a study recording wrist BCG alongside invasive arterial pressure during exercise showed that posture, workload, and heart rate each independently disrupt the transit-time calibration, because sympathetic activation alters arterial compliance independently of pressure. No vibration-based BP study has exceeded 25 subjects, all recruited healthy volunteers, every method required per-subject calibration, and none approaches the ISO 81060-2 standard of a mean error of 5 millimeters of mercury or less with a standard deviation of 8 or less in at least 85 representative subjects.

Against this uneven landscape, one recent development stands out as the field’s most clinically ambitious step. The SEISMIC-HF I study evaluated a wearable patch combining seismocardiography, ECG, and photoplethysmography in 310 heart failure patients with reduced ejection fraction undergoing clinically indicated right heart catheterization, aiming to estimate pulmonary capillary wedge pressure, the invasive gold standard of cardiac filling pressure and congestion. On a held-out test set, predicted pressures correlated with catheterization values at 0.74, with a mean difference of about 1 millimeter of mercury and limits of agreement within roughly 10 millimeters. The review treats this as an emerging endpoint that extends vibration sensing from flow and timing toward pressure-guided heart failure management, while cautioning that ambulatory performance, longitudinal calibration stability, and outcomes-guided trials remain untested.

The review closes with a diagnosis that applies well beyond cardiac vibrations. Four technical problems recur across every modality: sensor placement, where shifting an accelerometer two or three centimeters can distort waveforms more than the hemodynamic signal itself; posture and respiration, which modulate beat-to-beat stroke volume by up to 15 percent; motion artifact, which during walking exceeds the cardiac signal by an order of magnitude; and calibration drift, whose behavior over weeks to months has never been prospectively quantified. The authors also flag a neglected engineering dimension, noting that deep learning pipelines requiring tens of millions of operations per inference can exceed the compute and battery budget of a wearable device, and that no reviewed study reports inference latency or energy consumption. Their prescriptions are refreshingly inexpensive: adopt Bland-Altman reporting, recruit disease populations instead of healthy volunteers, measure calibration drift, and exploit newly available open datasets that pair wearable recordings with invasive references. The barrier, they conclude, is not hardware or algorithms but an incentive structure that rewards demonstrating success in ideal conditions over establishing where a method fails.

Subject of Research: Clinical validation readiness of wearable cardiac vibration signals for estimating central hemodynamic parameters

Article Title: Clinical Readiness of Hemodynamic Estimation from Cardiac Vibration Signals: An Endpoint-Specific Critical Review

Article References: Gamage, P. T., Weerasinghe, Y., Weerasinghe, P., & Kaya, M. (2026). Clinical Readiness of Hemodynamic Estimation from Cardiac Vibration Signals: An Endpoint-Specific Critical Review. Annals of Biomedical Engineering. https://doi.org/10.1007/s10439-026-04366-5

Image Credits: AI Generated

DOI: 10.1007/s10439-026-04366-5

Keywords: seismocardiography, ballistocardiography, gyrocardiography, kinocardiography, hemodynamic monitoring, stroke volume, cardiac output, ejection fraction, cuffless blood pressure, wearable sensors, Bland-Altman analysis, heart failure